T1	Participants 875 976	patients with coronary heart disease (CHD) or CHD risk equivalents (clinical trials.gov NCT00685776).
T2	Participants 977 1146	Eligible patients at National Cholesterol Education Program-Adult Treatment Panel III LDL-C treatment goal on a statin, with or without other lipid-modifying medications
T3	Participants 1727 1831	total of 2,757 patients were screened at 153 centers in 20 countries, and 1,623 patients were randomized
